Study the changes of amino acids and intestinal flora associated with insulin resistance in patients with colorectal cancer during Enhanced Recovery After Surgery (ERAS)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031345

Enrollment

Unknown

Registered

2020-03-28

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Insulin resistance group:None Intervention

No insulin resistance group:None Intervention

Eligibility

Sex/Gender

All

Age

12 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Surgical inpatients who need to undergo radical surgery for colorectal cancer within a limited period of time; 2. Aged 18-80 years.

Exclusion criteria

Exclusion criteria: 1. With diabetes or impaired glucose tolerance; 2. Patients with distant metastases; 3. Renal insufficiency requiring dialysis in patients with liver insufficiency (Child - Pugh grade B or above); 4. With an eating disorder caused by obstruction of the digestive tract; 5. Patients with preoperative insulin resistance (increased insulin resistance index, decreased insulin sensitivity index of Bennett, abnormal cell function index); 6. Patients with terminal ileostomy during operation.

Design outcomes

Primary

Measure	Time frame
Serum amino acid spectrum;Intestinal flora structure;	—

Countries

China

Contacts

Public ContactYunpeng Zhang

Tongren Hospital Affiliated to Medical College of Shanghai Jiaotong University

ZYP3452@shtrhospital.com+86 18917129375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026